2011
DOI: 10.1016/j.anucene.2011.06.018
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of palladium-103 production and IR07-103Pd brachytherapy seed preparation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…The results were tabulated in Table 2. It can be seen that a very small difference exists between our reported normalized geometry function and the other similar work [22,25,28,30,31]. Additionally, radial dose function was tabulated in Table 3 which includes TLD measured and MCderived values for the same source of 103 Pd.…”
Section: Studymentioning
confidence: 79%
See 1 more Smart Citation
“…The results were tabulated in Table 2. It can be seen that a very small difference exists between our reported normalized geometry function and the other similar work [22,25,28,30,31]. Additionally, radial dose function was tabulated in Table 3 which includes TLD measured and MCderived values for the same source of 103 Pd.…”
Section: Studymentioning
confidence: 79%
“…GNPs and other nanoparticles have been studied for their potential dose enhancement effect in brachytherapy [21][22][23]. In Monte Carlo (MC) studies, a newly fabricated 103 Pd source was investigated for its dosimetric property for application in brachytherapy of prostate cancer [24][25][26][27][28]. They confirmed its dosimetric suitability for brachytherapy of prostate cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the electrodeposition experiments were performed in acidic sulphate media using RhCl 3 .3H 2 O, Rh 2 (SO 4 ) 3 . The radiochemical processing of the irradiation targets involved (a) dissolution, (b) radiochemical separation of 103 -Pd from the Rh target solution and (c) recovery of 103 -Pd as the final product from the organic phases [22]. After the chemical separation process, 103 -Pd radioactive material is absorbed uniformly in the resin Amberlite IR-93 resin (20-50 mesh) bead to encapsulate inside the titanium capsule.…”
Section: -Pd Source Descriptionmentioning
confidence: 99%
“…• Low-dose-rate sources (LDR): Less than 2 Gy/h radioisotopes with low-energy photon emitters like 103 Pd and 125 I are used. Table 1 shows examples of radioisotopes commonly used in brachytherapy for the three mentioned categories [10].…”
Section: Introductionmentioning
confidence: 99%
“…Excitation function of 103 Rh(d,2n) 103 Pd reaction by ALICE/91, ALICE/ASH and TALYS-1.2 codes, and experimental data[10].…”
mentioning
confidence: 99%